Highlights in bladder and prostate cancer at PROCSA/BLADDR 2023

In this podcast, we’ll be covering highlights from the PROCSA/BLADDR 2023 Meeting, which took place in Valencia, Spain, such as the evolution of targeted therapies and novel biomarker driven studies in prostate cancer, as well as trimodal therapy for non-muscle invasive bladder cancer. Hear from Rob Jones (The University of Glasgow, Glasgow, UK), Bertrand Tombal (Université catholique de Louvain, Ottignies-Louvain-la-Neuve, Belgium), Daniele Raggi (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy), Bram De Laere (Ghent University, Ghent, Belgium), Paul Sargos (Institut Bergonié, Bordeaux, France), Felix Guerrero-Ramos (Hospital Universitario 12 de Octubre, Madrid, Spain), Eva Compérat (Medical University of Vienna, Vienna, Austria).